Home > Qtrly Results > NEULAND LABORATORIES

NEULAND LABORATORIES
Quarterly Results Analysis [Dec2023]

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
Audited
Mar2022
Audited
Revenues ₹393 Cr ₹418 Cr ₹363 Cr ₹407 Cr ₹269 Cr ₹294 Cr ₹221 Cr ₹256 Cr
Expenses ₹272 Cr ₹280 Cr ₹266 Cr ₹287 Cr ₹215 Cr ₹224 Cr ₹193 Cr ₹217 Cr
Operating Income ₹121 Cr ₹137 Cr ₹97 Cr ₹120 Cr ₹54 Cr ₹69 Cr ₹29 Cr ₹39 Cr
Other Income ₹2 Cr ₹3 Cr ₹2 Cr ₹8 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr
Interest ₹4 Cr ₹4 Cr ₹2 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr
Depreciation ₹15 Cr ₹15 Cr ₹14 Cr ₹13 Cr ₹13 Cr ₹13 Cr ₹13 Cr ₹12 Cr
Profit Before Tax ₹104 Cr ₹122 Cr ₹83 Cr ₹110 Cr ₹39 Cr ₹53 Cr ₹13 Cr ₹24 Cr
Profit After Tax ₹81 Cr ₹89 Cr ₹62 Cr ₹85 Cr ₹31 Cr ₹38 Cr ₹10 Cr ₹22 Cr
EPS ₹63.09 ₹69.18 ₹47.96 ₹65.53 ₹23.68 ₹29.81 ₹7.73 ₹16.88
Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES 5.7% -7.9% 288.4%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

NEULAND LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-5.97 %

Y-o-Y

45.90 %

Quarters Revenues % Change
Dec2023 ₹393 Cr
-5.97
Sep2023 ₹418 Cr
15.08
Jun2023 ₹363 Cr
-10.83
Mar2023 ₹407 Cr
51.19
Dec2022 ₹269 Cr
-8.33
Sep2022 ₹294 Cr
32.80
Jun2022 ₹221 Cr
-13.56
Mar2022 ₹256 Cr -

NEULAND LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-11.80 %

Y-o-Y

124.22 %

Quarters Operating Profit % Change
Dec2023 ₹121 Cr
-11.80
Sep2023 ₹137 Cr
41.86
Jun2023 ₹97 Cr
-19.14
Mar2023 ₹120 Cr
121.62
Dec2022 ₹54 Cr
-21.96
Sep2022 ₹69 Cr
142.27
Jun2022 ₹29 Cr
-26.41
Mar2022 ₹39 Cr -
Operating Margins
Q-o-Q

-6.20 %

Y-o-Y

53.66 %

Quarters Operating Margin% % Change
Dec2023 30.87%
-6.20
Sep2023 32.91%
23.26
Jun2023 26.7%
-9.31
Mar2023 29.44%
46.54
Dec2022 20.09%
-14.84
Sep2022 23.59%
82.44
Jun2022 12.93%
-14.88
Mar2022 15.19% -

NEULAND LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-8.80 %

Y-o-Y

166.43 %

Quarters Profit After Tax % Change
Dec2023 ₹81 Cr
-8.80
Sep2023 ₹89 Cr
44.23
Jun2023 ₹62 Cr
-26.81
Mar2023 ₹85 Cr
176.76
Dec2022 ₹31 Cr
-20.58
Sep2022 ₹38 Cr
285.93
Jun2022 ₹10 Cr
-54.24
Mar2022 ₹22 Cr -
PAT Margins
Q-o-Q

-3.00 %

Y-o-Y

82.56 %

Quarters PAT Margin(%) % Change
Dec2023 20.72 %
-3.00
Sep2023 21.36 %
25.28
Jun2023 17.05 %
-17.91
Mar2023 20.77 %
83.00
Dec2022 11.35 %
-13.36
Sep2022 13.1 %
190.47
Jun2022 4.51 %
-47.00
Mar2022 8.51 % -

NEULAND LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-8.80 %

Y-o-Y

166.43 %

Quarters EPS % Change
Dec2023 ₹63.09
-8.80
Sep2023 ₹69.18
44.25
Jun2023 ₹47.96
-26.81
Mar2023 ₹65.53
176.73
Dec2022 ₹23.68
-20.56
Sep2022 ₹29.81
285.64
Jun2022 ₹7.73
-54.21
Mar2022 ₹16.88 -

You may also like the below Video Courses